Company TaiMed Biologics Inc.




Biotechnology & Medical Research

End-of-day quote Taipei Exchange 06:00:00 2024-07-22 pm EDT 5-day change 1st Jan Change
86.50 TWD -0.69% Intraday chart for TaiMed Biologics Inc. -1.82% +5.49%

Business description: TaiMed Biologics Inc.

TaiMed Biologics Inc. is a Taiwan-based company principally engaged in the research and development of new medicines. The Company mainly provides ibalizumab (TMB-355) and TMB-360, which are applied in the treatment of acquired immune deficiency syndrome (AIDS), and protease inhibitor (TMB-607), which is applied as pro-drugs for AIDS. The Company's ibalizumab is a humanized monoclonal antibody, which can interfere with the penetration of the virus into the cell. Its protease inhibitor uses nanotechnology formulation for subcutaneous and/or intramuscular injections.

Sales by Activity: TaiMed Biologics Inc.

Fiscal Period: December20192020202120222023

Research and Development and Sales of New Drugs

705M 722M 413M 563M 492M
See all business segments

Geographical breakdown of sales: TaiMed Biologics Inc.

Fiscal Period: December20192020202120222023


705M 722M 413M 563M 492M
See all geographic segments

Managers: TaiMed Biologics Inc.

Insider TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 08-05-31
Corporate Officer/Principal - -

Members of the board: TaiMed Biologics Inc.

Insider TitleAgeSince
Chairman - 09-06-11
Director/Board Member 62 17-05-25
Director/Board Member 66 18-09-06
Director/Board Member 68 20-06-03
Composition of the Board of Directors

Shareholders: TaiMed Biologics Inc.

National Development Fund of The Executive Yuan
14.84 %
40,512,012 14.84 % 112 M NT$
Ruen Hua Dyeing & Weaving Co., Ltd.
6.730 %
18,379,028 6.730 % 51 M NT$
10,507,849 3.848 % 29 M NT$
10,410,455 3.812 % 29 M NT$
3,552,867 1.301 % 10 M NT$
List of TAIMED BIOLOGICS INC. shareholders

Company details: TaiMed Biologics Inc.

TaiMed Biologics, Inc.

3rd Floor No. 607 Ruiguang Road

114 92, Taipei

address TaiMed Biologics Inc.(4147)

Bio Therapeutic Drugs

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.69%-1.82%-13.50%+37.96% 720M
+0.10%+0.50%+37.46%+144.79% 127B
+0.50%-2.28%+45.90%+80.93% 114B
-0.19%+1.32%-10.42%+60.13% 27.9B
-2.76%-3.85%-22.32%-70.51% 20.63B
-0.29%+4.13%-29.31%-32.94% 17.63B
+3.83%+6.46%-16.23%-48.39% 16.67B
-1.40%-1.45%-42.94%-74.90% 15.04B
+0.30%+0.85%+45.85%+48.07% 14.64B
-1.11%-0.61%+39.73%+118.60% 13.96B
Average -0.17%+0.18%+3.42%+26.37% 36.76B
Weighted average by Cap. +0.09%-0.33%+24.48%+75.17%
See all sector performances
  1. Stock Market
  2. Equities
  3. 4147 Stock
  4. Company TaiMed Biologics Inc.